Emcure Pharmaceuticals Unit to Acquire Remaining Shares in Canada's Mantra Pharma for C$50 Million
() -- Emcure Pharmaceuticals (NSE:EMCURE, BOM:544210) said its subsidiary Marcan Pharmaceuticals has agreed to acquire all outstanding Class E special shares of its step-down subsidiary, Mantra Pharma, for 50 million Canadian dollars. The transaction, subject to customary closing formalities under Canadian law, will le